Patient blood management in obstetrics

International Anesthesiology Clinics

Volumn 52, Issue 3, 2014, Pages 85-100

  Waters, Jonathan H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPROST; CARBOPROST TROMETAMOL; CITRIC ACID; ERGOT ALKALOID; ERYTHROPOIETIN; FIBRINOGEN CONCENTRATE; HEPARIN; METHYLERGOMETRINE MALEATE; MISOPROSTOL; OXYTOCIN; TRANEXAMIC ACID; UTEROTONIC AGENT;

ARTICLE; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD BANK; BLOOD DONOR; BLOOD RESERVOIR; BLOOD SALVAGE; BLOOD SAMPLING; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; HEMODILUTION; HIGH RISK POPULATION; HUMAN; INTERVENTIONAL RADIOLOGY; OBSTETRIC HEMORRHAGE; PERINATAL PERIOD; POSTPARTUM HEMORRHAGE; PREDICTION; PRENATAL CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT CONTRAINDICATION; ALLOTRANSPLANTATION; FEMALE; MATERNAL MORTALITY; MORTALITY; PREGNANCY; PROCEDURES;

BLOOD TRANSFUSION; FEMALE; HUMANS; MATERNAL MORTALITY; POSTPARTUM HEMORRHAGE; PREGNANCY; PRENATAL CARE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84903136302     PISSN: 00205907     EISSN: 15371913     Source Type: Journal    
DOI: 10.1097/AIA.0000000000000015     Document Type: Article

References (64)

1. Blundell J. Experiments of the transfusion of blood by the syringe. Med Chir Trans. 1818;9:56-75.
2. Blundell J. Some account of a case of obstinate vomiting, in which an attempt was made to prolong life by injection of blood into the veins. Med Chir Trans. 1819;10: 295-311.
3. Pfuntner A, Wier LM, Stocks C. Healthcare Cost and Utilization Project. Statistical Brief #149. Most frequent procedures performed in US hospitals, 2010. Available at: Http://www.hcup-us.ahrq.gov/reports/statbriefs/sb149.pdf. Accessed June 16, 2013.
4. Utter GH, Reed WF, Lee TH, et al. Transfusion-Associated microchimerism. Vox Sang. 2007;93:188-195. (Pubitemid 47373988)
5. World Health Organization. Global database on anaemia. Worldwide prevalence of anaemia 1993-2005. Available at: Http://whqlibdoc.who.int/ publications/2008/ 9789241596657-eng.pdf. Accessed July 5, 2013.
6. Schwartz WJ III, Thurnau GR. Iron deficiency anemia in pregnancy. Clin Obstet Gynecol. 1995;38:443-454.
7. Galloway R, McGuire J. Determinants of compliance with iron supplementation: Supplies, side effects, or psychology? Soc Sci Med. 1994;39:381-390.
8. Meyer JW, Eichhorn KH, Vetter K, et al. Does recombinant human erythropoietin not only treat anemia but reduce postpartum (emotional) distress as well? J Perinat Med. 1995;23:99-109.
9. Perez EM, Hendricks MK, Beard JL, et al. Mother-infant interactions and infant development are altered by maternal iron deficiency anemia. J Nutr. 2005;135:850-855. (Pubitemid 40464115)
10. Barton DP, Joy MT, Lappin TR, et al. Maternal erythropoietin in singleton pregnancies: A randomized trial on the effect of oral hematinic supplementation. Am J Obstet Gynecol. 1994;170:896-901. (Pubitemid 24224721)
11. Brecher ME, Goodnough LT. The rise and fall of preoperative autologous blood donation. Transfusion. 2001;41:1459-1462. (Pubitemid 34072665)
12. O'Dwyer G, Mylotte M, Sweeney M, et al. Experience of autologous blood transfusion in an obstetrics and gynaecology department. Br J Obstet Gynaecol. 1993;100:571-574. (Pubitemid 23186363)
13. Lindenbaum CR, Schwartz IR, Chibber G, et al. Safety of predeposit autologous blood donation in the third trimester of pregnancy. J Reprod Med. 1990;35:537-540. (Pubitemid 20165443)
14. The California Maternal Quality Care Collaborative (CMQCC). CMQCC Obstetric Hemorrhage Hospital Level Implementation Guide. Palo Alto, CA: California Maternal Quality Care Collaborative; 2010. Available at: Http://www.cmqcc.org/ob-hemorrhage. Accessed July 13, 2013.
15. Dilla AJ, Waters JH, Yazer MH. Clinical validation of risk stratification criteria for peripartum hemorrhage. Obstet Gynecol. 2013;122:120-126.
16. Highmore W. Practical remarks on an overlooked source of blood-supply for transfusion in post-partum hemorrhage. Lancet. 1874;1:89.
17. Gregoretti S. Suction-induced hemolysis at various vacuum pressures: Implications for intraoperative blood salvage. Transfusion. 1996;36:57-60. (Pubitemid 26057264)
18. Clague CT, Blackshear PL Jr. A low-hemolysis blood aspirator conserves blood during surgery. Biomed Instrum Technol. 1995;29:419-424.
19. Sutera SP. Flow-induced trauma to blood cells. Circ Res. 1977;41:2-8.
20. Ronai AK, Glass JJ, Shapiro AS. Improving autologous blood harvest: Recovery of red cells from sponges and suction. Anaesth Intens Care. 1987;15:421-424.
21. Haynes SL, Bennett JR, Torella F, et al. Does washing swabs increase the efficiency of red cell recovery by cell salvage in aortic surgery? Vox Sang. 2005;88:244-248. (Pubitemid 40704897)
22. Saarla E. Autotransfusion: A review. Ann Clin Res. 1981;13:48-56.
23. Oller DW, Rice CL, Herman CM, et al. Heparin versus citrate anticoagulation in autotransfusion. J Surg Res. 1976;20:333-340.
24. Halpern NA, Alicea M, Seabrook B, et al. Cell saver autologous transfusion: Metabolic consequences of washing blood with normal saline. J Trauma. 1996;41:407-415. (Pubitemid 26318067)
25. Halpern NA, Alicea M, Seabrook B, et al. Isolyte S, a physiologic multielectrolyte solution, is preferable to normal saline to wash cell saver salvaged blood: Conclusions from a prospective, randomized study in a canine model. Crit Care Med. 1997;25: 2031-2038. (Pubitemid 28007242)
26. Waters JH, Biscotti C, Potter P, et al. Amniotic fluid removal during cell-salvage in the cesarean section patient. Anesthesiology. 2000;92:1531-1536. (Pubitemid 30412469)
27. Hussain S, Clyburn P. Cell salvage-induced hypotension and London buses. Anaesthesia. 2010;65:661-663.
28. Rainaldi MP, Tazzari PL, Scagliarini G, et al. Blood salvage during caesarean section. Br J Anaesth. 1998;80:195-198. (Pubitemid 28069769)
29. Grimes DA. A simplified device for intraoperative autotransfusion. Obstet Gynecol. 1988;72:947-950.
30. Jackson SH, Lonser RE. Safety and effectiveness of intracesarean blood salvage (letter). Transfusion. 1993;33:181. (Pubitemid 23060553)
31. Bernstein HH, Rosenblatt MA, Gettes M, et al. The ability of the Haemonetics 4 Cell Saver System to remove tissue factor from blood contaminated with amniotic fluid. Anesth Analg. 1997;85:831-833. (Pubitemid 27418888)
32. Boudreaux JP, Bornside GH, Cohn I Jr. Emergency autotransfusion: Partial cleansing of bacteria-laden blood by cell washing. J Trauma. 1983;23:31-35. (Pubitemid 13181948)
33. Waters JH, Tuohy MJ, Hobson DF, et al. Bacterial reduction by cell salvage washing and leukocyte depletion filtration. Anesthesiology. 2003;99:652-655. (Pubitemid 37051981)
34. Smith RN, Yaw PB, Glover JL. Autotransfusion of contaminated intraperitoneal blood: An experimental study. J Trauma. 1978;18:341-344. (Pubitemid 8367548)
35. Wollinsky KH, Oethinger M, Büchele M, et al. Autotransfusion- bacterial contamination during hip arthroplasty and efficacy of cefuroxime prophylaxis. Acta Orthop Scand. 1997;68:225-230. (Pubitemid 27341572)
36. ACOG Committee Opinion. Placenta accreta. Number 266. Int J Gynecol Obstet. 2002; 77:77-78.
37. Obstetric Anaesthetists' Association/The Association of Anaesthetists of Great Britain and Ireland (OAA/AAGBI). OAA/AAGBI Guidelines for Obstetric Anaesthetic Services. Revised edition. London: OAA/AAGBI: 2005;25.
38. Royal College of Obstetricians and Gynaecologists. Blood transfusion in obstetrics. Green-Top guideline no. 47, 2008. Available at: Http://www.rcog.org. uk/womens-health/ clinical-guidance/blood-Transfusions-obstetrics-green-Top-47. Accessed August 14, 2012.
39. National Institute for Health and Clinical Excellence. IPG 144: Intra-operative blood cell salvage in obstetrics-guidance. 2005. Available at: Http://www.nice.org.uk/ nicemedia/pdf/ip/IPG144guidance.pdf. Accessed August 14, 2012.
40. Royal College of Obstetricians and Gynaecologists. Why Mothers Die. Confidential Enquiry Into Maternal and Child Health 2000-2002. London: Royal College of Obstetricians and Gynaecologists; 2004.
41. Seror J, Allouche C, Elhaik S. Use of Sengstaken-Blakemore tube in massive postpartum hemorrhage: A series of 17 cases. Acta Obstet Gynecol Scand. 2005;84:660-664. (Pubitemid 40917390)
42. AbdRabbo SA. Stepwise uterine devascularization: A novel technique for management of uncontrolled postpartum hemorrhage with preservation of the uterus. Am J Obstet Gynecol. 1994;171:694-700. (Pubitemid 24312350)
43. O'Leary JA. Uterine artery ligation in the control of postcesarean hemorrhage. J Reprod Med. 1995;40:189-193.
44. Price N, B-Lynch C. Technical description of the B-Lynch brace suture for treatment of massive postpartum hemorrhage and review of published cases. Int J Fertil Womens Med. 2005;50:148-163. (Pubitemid 46489170)
45. B-Lynch C, Coker A, Lawal AH, et al. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: An alternative to hysterectomy? Five cases reported. Br J Obstet Gynaecol. 1997;104:372-375. (Pubitemid 27112674)
46. Vendentham S, Goodwin SC, McLucas B, et al. Uterine artery embolization: An underused method of controlling pelvic hemorrhage. Am J Obstet Gynecol. 1997;17:938-948. (Pubitemid 27202959)
47. Alvarez M, Lockwood CJ, Ghidini A, et al. Prophylactic and emergent arterial catheterization for selective embolization in obstetric hemorrhage. Am J Perinatol. 1992;9:441-444.
48. British Medical Association and Royal Pharmaceutical Society of Great Britain. Obstetrics, gynaecology, and urinary-Tract disorders. In: British National Formulary. 42nd ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2001;373-376.
49. ACOG Educational Bulletin. Postpartum hemorrhage. Number 243. Int J Gynecol Obstet. 1998;61:79-86.
50. Balki M, Ronayne M, Davies S, et al. Minimum oxytocin dose requirement after cesarean delivery for labor arrest. Obstet Gynecol. 2006;107:45-50.
51. Sarna MC, Soni AK, Gomez M, et al. Intravenous oxytocin in patients undergoing elective cesarean section. Anesth Analg. 1997;84:753-756. (Pubitemid 27147696)
52. Svanstrsm MC, Biber B, Hanes M, et al. Signs of myocardial ischaemia after injection of oxytocin: A randomized double-blind comparison of oxytocin and methylergometrine during caesarean section. Br J Anaesth. 2008;100:683-689.
53. Lacy CF, Armstrong LL, Goldman MP, et al. Drug Information Handbook. 14th ed. Hudson, OH: Lexi-Comp; 2006.
54. Muller-Schweinitzer E, Weidemann H. Basic pharmacological properties. In: Berde B, Schild HO. ed. Ergot Alkaloids and Related Compounds. Handbook of Experimental Pharmacology. Vol 49; Berlin: Springer-Verlag: 1978;87-196.
55. Anonymous. The management of postpartum haemorrhage. Drug Ther Bull. 1992;30:89-92.
56. CRASH-2 Collaborators. Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: An exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011;377:1096-1101.
57. Gülmezoglu AM, Souza JP, Chou D, et al. WHO Guidelines for the Management of Postpartum Hemorrhage and Retained Placenta. Geneva, Switzerland: World Health Organization Press; 2009. Available at: Http://whqlibdoc.who.int/ publications/2009/ 9789241598514-eng.pdf. Accessed August 14, 2012.
58. Cortet M, Deneux-Tharaux C, Dupont C, et al. Association between fibrinogen level and severity of postpartum haemorrhage: Secondary analysis of a prospective trial. Br J Anaesth. 2012;108:984-989.
59. Bell SF, Rayment R, Collins PW, et al. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric hemorrhage. Int J Obstet Anesth. 2010; 19:218-223.
60. Franchini M, Franchi M, Bergamini V, et al. A critical review on the use of recombinant factor VIIa in life-Threatening obstetric postpartum hemorrhage. Semin Thromb Hemost. 2008;34:104-112. (Pubitemid 351640886)
61. Leighton BL, Wall MH, Lockhart EM, et al. Use of recombinant Factor VIIa in patients with amniotic fluid embolism: A systematic review of case reports. Anesthesiology. 2011;115:1201-1208.
62. Brabin BJ, Hakimi M, Pelletier D. An analysis of anemia and pregnancy-related maternal mortality. J Nutr. 2001;131:604S-615S. (Pubitemid 32115340)
63. Simmon L, Stephenson-Famy A, Easterling T. Optimization of oxygen delivery in a Jehovah's Witness with severe anaemia after postpartum hemorrhage. Obstet Med. 2012;5:39-41.
64. Lee JH, Choi SR, Chin YJ, et al. The care of a Jehovah's Witness with life-Threatening anemia refusing ventilator care. Korean J Crit Care Med. 2010;25:52-55.